US2007275036A1PendingUtilityA1

Avian follistatin product

Assignee: CELLDYNE BIOPHARMA LLCPriority: May 18, 2006Filed: May 17, 2007Published: Nov 29, 2007
Est. expiryMay 18, 2026(expired)· nominal 20-yr term from priority
A23L 15/00A61K 38/1709A61K 35/57A23V 2002/00A23L 33/17
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described herein are avian follistatin products, and methods for producing such products, in which such products are effective for a variety of conditions, including increasing muscle mass. Avian follistatin products described herein are packaged as dietary supplements or nutritional supplements are useful in muscle regeneration.

Claims

exact text as granted — not AI-modified
1 . A sports nutrition composition comprising follistatin and avian egg yolk membrane, wherein the avian egg yolk membrane is substantially dehydrated and free of viable pathogens.  
   
   
       2 . The sports nutrition composition of  claim 1 , wherein the avian egg yolk membrane is from a fertilized egg.  
   
   
       3 . The sports nutrition composition of  claim 1  comprising avian egg yolk.  
   
   
       4 . The sports nutrition composition of  claim 1 , wherein the avian egg yolk membrane is from a chicken egg, duck egg, or ostrich egg.  
   
   
       5 . The sports nutrition composition of  claim 4 , wherein the avian egg yolk membrane is from a chicken egg.  
   
   
       6 . The sports nutrition composition of  claim 1 , further comprising a pharmaceutically acceptable ingredient.  
   
   
       7 . A method for increasing muscle mass, comprising administering to a subject the sports nutrition composition of  claim 1 .  
   
   
       8 . A process for making a follistatin-containing sports nutrition composition, the method comprising sterilizing an avian egg yolk or avian egg yolk membrane, wherein 
 (i) the avian egg yolk or avian egg yolk membrane is from a fertilized avian egg; or    (ii) the avian egg yolk or avian egg yolk membrane is supplemented with a composition containing follistatin.    
   
   
       9 . The process of  claim 8 , wherein the avian egg yolk or avian egg yolk membrane is from a fertilized avian egg.  
   
   
       10 . The process of  claim 8 , wherein the avian egg yolk is dehydrated prior to the sterilization.

Join the waitlist — get patent alerts

Track US2007275036A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.